1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Tempest Therapeutics, Inc.

Tempest Therapeutics, Inc.

TPST
Tempest Therapeutics, Inc.US flagNASDAQ Capital Market
0.97
USD
-0.02
- -
4.29MMarket Cap

Income Statement (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- Operating Expenses
19
27
35
29
42
27
+ Selling, General & Admin
5
10
12
12
14
14
+ Research & Development
14
17
23
17
28
13
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-19
-27
-35
-29
-42
-27
- Non-Operating (Income) Loss
- -
1
1
- -
- -
- -
+ Interest Expense, Net
- -
1
1
- -
- -
- -
+ Interest Expense
- -
1
2
1
1
- -
- Interest Income
- -
- -
1
1
1
1
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
- -
Pretax Income
-19
-28
-36
-29
-42
-26
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-19
-28
-36
-29
-42
-26
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-19
-28
-36
-29
-42
-26
- Minority Interest
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-19
-28
-36
-29
-42
-26
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-19
-28
-36
-29
-42
-26
EBIT
-19
-27
-35
-29
-42
-27
EBITDA
-19
-27
-34
-29
-42
-26
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
EBITA
-19
-27
-35
-29
-42
-27
Gross Margin (%)
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
1
- -
- -
- -
Basic Weighted Avg Shares
1
- -
1
1
3
4
Basic EPS, GAAP
-37.63
-97.07
-40.17
-24.87
-12.37
-6.33
Basic EPS from Cont Ops
-37.63
-97.07
-40.17
-24.87
-12.37
-6.33
Diluted Weighted Avg Shares
1
- -
1
1
3
4
Diluted EPS, GAAP
-37.63
-97.07
-40.17
-24.87
-12.37
-6.33
Diluted EPS from Cont Ops
-37.63
-97.07
-40.17
-24.87
-12.37
-6.33

Balance Sheet (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
20
69
33
40
31
8
+ Cash, Cash Equivalents & STI
19
52
31
39
30
8
+ Cash & Cash Equivalents
19
52
31
39
30
8
+ ST Investments
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
15
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
15
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
+ Other ST Assets
1
2
1
1
1
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
3
4
13
11
10
9
+ Property, Plant & Equip, Net
3
4
13
11
10
8
+ Property, Plant & Equip
3
5
14
12
11
10
- Accumulated Depreciation
- -
1
1
1
1
1
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
1
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
1
Total Assets
23
73
46
52
41
17
+ Payables & Accruals
2
18
5
3
5
2
+ Accounts Payable
1
1
1
1
2
1
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
17
4
2
3
1
+ ST Debt
1
1
1
5
7
1
+ ST Borrowings
- -
- -
- -
4
6
- -
+ ST Finance Leases
1
1
1
1
1
1
+ Other ST Liabilities
1
1
1
2
2
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
1
1
1
2
2
- -
Total Current Liabilities
3
20
7
9
14
3
+ LT Debt
2
17
21
15
8
7
+ LT Borrowings
- -
15
10
6
- -
- -
+ LT Finance Leases
2
2
10
9
8
7
+ Other LT Liabilities
87
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
87
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
88
17
21
15
8
7
Total Liabilities
92
37
28
25
22
10
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
3
136
154
192
226
240
+ Common Stock
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
3
136
154
192
226
240
- Treasury Stock
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-72
-100
-136
-165
-207
-233
+ Other Equity
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-69
36
18
27
19
7
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
Total Equity
-69
36
18
27
19
7
Total Liabilities & Equity
23
73
46
52
41
17
Shares Outstanding
1
1
1
2
3
5
Number of Employees
- -
- -
- -
- -
- -
- -
Capital Leases - Total
2
3
12
10
9
8
Net Debt
-19
-37
-21
-29
-24
-8
Net Debt to Equity
27.36
-101.78
-115.17
-107.15
-125.03
-115.58
Tangible Common Equity Ratio
-300.89
49.31
39.3
51.87
46.1
39.38
Current Ratio
6.15
3.44
4.53
4.29
2.21
2.5
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-19
-28
-36
-29
-42
-26
+ Depreciation & Amortization
- -
- -
1
- -
- -
- -
+ Non-Cash Items
1
3
3
4
7
4
+ Stock-Based Compensation
- -
1
2
3
5
3
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
1
2
2
2
1
+ Chg in Non-Cash Work Cap
-1
-1
1
-3
2
-5
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
1
- -
- -
1
+ Inc (Dec) in Accts Payable
-1
1
1
-1
3
-5
+ Inc (Dec) in Other
- -
-1
-2
-2
-1
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-19
-26
-31
-27
-33
-27
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
-1
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
-1
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
33
9
36
29
7
+ Increase in Capital Stock
- -
33
9
36
29
7
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
-1
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
15
-5
- -
-4
-6
+ Cash From Debt
- -
15
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
-5
- -
-4
-6
+ Other Financing Activities
35
11
7
- -
- -
3
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
35
59
11
36
24
4
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
Net Changes in Cash
16
33
-20
8
-9
-23
EBITDA
-19
-27
-34
-29
-42
-26
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
Free Cash Flow
-19
-26
-32
-28
-33
-27
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-11
-36
-28
-38
-33
Free Cash Flow per Basic Share
-37.36
-89.49
-35.59
-23.21
-9.89
-6.46
Price/Free Cash Flow
-11.23
-0.78
-0.44
-2.49
-1.13
-0.44
Cash Flow to Net Income
0.99
0.92
0.87
0.93
0.79
1.02
Capital Expenditures
- -
- -
-1
- -
- -
- -